Search research articles
Contact Us
Filters
Showing results (51-60 of 81) with videos related to
Page
of 9
Sort By:
Molecular Cell
|
November 24, 2015
Transcription of Mammalian cis-Regulatory Elements Is Restrained by Actively Enforced Early Termination
Liv M I Austenaa, Iros Barozzi, Marta Simonatto, et al.
Cancer Cell
|
March 22, 2024
Mapping functional to morphological variation reveals the basis of regional extracellular matrix subversion and nerve invasion in pancreatic cancer
Pierluigi Di Chiaro, Lucia Nacci, Fabiana Arco, et al.
Nature Communications
|
April 23, 2020
Exploiting evolutionary steering to induce collateral drug sensitivity in cancer
Ahmet Acar, Daniel Nichol, Javier Fernandez-Mateos, et al.
Nature Genetics
|
January 24, 2017
Acquired CYP19A1 amplification is an early specific mechanism of aromatase inhibitor resistance in ERα metastatic breast cancer
Luca Magnani, Gianmaria Frige, Raffaella Maria Gadaleta, et al.
Nature Communications
|
November 28, 2015
Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasion
Van T M Nguyen, Iros Barozzi, Monica Faronato, et al.
Nature Genetics
|
May 27, 2017
Corrigendum: Acquired CYP19A1 amplification is an early specific mechanism of aromatase inhibitor resistance in ERα metastatic breast cancer
Luca Magnani, Gianmaria Frigè, Raffaella Maria Gadaleta, et al.
Genes & Development
|
April 1, 2014
HDAC-regulated myomiRs control BAF60 variant exchange and direct the functional phenotype of fibro-adipogenic progenitors in dystrophic muscles
Valentina Saccone, Silvia Consalvi, Lorenzo Giordani, et al.
Journal of Hepatology
|
March 11, 2023
MYC determines lineage commitment in KRAS-driven primary liver cancer development
Luana D'Artista, Athina Anastasia Moschopoulou, Iros Barozzi, et al.
Nature Communications
|
August 8, 2019
Author Correction: Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasion
Van T M Nguyen, Iros Barozzi, Monica Faronato, et al.
Nature Medicine
|
July 25, 2018
Enhancer mapping uncovers phenotypic heterogeneity and evolution in patients with luminal breast cancer
Darren K Patten, Giacomo Corleone, Balázs Győrffy, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 81) with videos related to
Sort By:
Page
of 9
Molecular Cell
|
November 24, 2015
Transcription of Mammalian cis-Regulatory Elements Is Restrained by Actively Enforced Early Termination
Liv M I Austenaa, Iros Barozzi, Marta Simonatto, et al.
Cancer Cell
|
March 22, 2024
Mapping functional to morphological variation reveals the basis of regional extracellular matrix subversion and nerve invasion in pancreatic cancer
Pierluigi Di Chiaro, Lucia Nacci, Fabiana Arco, et al.
Nature Communications
|
April 23, 2020
Exploiting evolutionary steering to induce collateral drug sensitivity in cancer
Ahmet Acar, Daniel Nichol, Javier Fernandez-Mateos, et al.
Nature Genetics
|
January 24, 2017
Acquired CYP19A1 amplification is an early specific mechanism of aromatase inhibitor resistance in ERα metastatic breast cancer
Luca Magnani, Gianmaria Frige, Raffaella Maria Gadaleta, et al.
Nature Communications
|
November 28, 2015
Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasion
Van T M Nguyen, Iros Barozzi, Monica Faronato, et al.
Nature Genetics
|
May 27, 2017
Corrigendum: Acquired CYP19A1 amplification is an early specific mechanism of aromatase inhibitor resistance in ERα metastatic breast cancer
Luca Magnani, Gianmaria Frigè, Raffaella Maria Gadaleta, et al.
Genes & Development
|
April 1, 2014
HDAC-regulated myomiRs control BAF60 variant exchange and direct the functional phenotype of fibro-adipogenic progenitors in dystrophic muscles
Valentina Saccone, Silvia Consalvi, Lorenzo Giordani, et al.
Journal of Hepatology
|
March 11, 2023
MYC determines lineage commitment in KRAS-driven primary liver cancer development
Luana D'Artista, Athina Anastasia Moschopoulou, Iros Barozzi, et al.
Nature Communications
|
August 8, 2019
Author Correction: Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasion
Van T M Nguyen, Iros Barozzi, Monica Faronato, et al.
Nature Medicine
|
July 25, 2018
Enhancer mapping uncovers phenotypic heterogeneity and evolution in patients with luminal breast cancer
Darren K Patten, Giacomo Corleone, Balázs Győrffy, et al.
Page
of 9